During a recent Senate Finance Committee meeting, Robert F. Kennedy Jr. addressed President Donald Trump's stance on the regulation of mifepristone, a drug commonly used in medication abortions. Kennedy stated that while Trump has not taken a definitive position on the matter, the President is interested in understanding the safety of mifepristone and other drugs.
Mifepristone, in combination with misoprostol, is a key component of medication abortions in the United States, which have become the primary method of abortion in the country. According to the Guttmacher Institute, over 63% of all abortions in the US in 2023 were conducted using medication abortion.
